AMGEN Profit Margin

AMGEN (AMGN) currently reports a profit margin of 22.95% as of June 2026. That compares with 18.96% in the prior-year period — up 21.0% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore AMGEN's profit margin history and peer comparisons.

AMGEN's profit margin increased from 18.96% to 22.95% — a 21.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AMGEN's profit margin of 22.95% is higher than the Healthcare sector average of 13.89%. That is roughly 65.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AMGEN's current 22.95% should be judged against Healthcare norms (sector average: 13.89%) and against AMGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 22.95%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for AMGEN, and consider following AMGN for alerts when major investors trade the stock.